• The intervention and trial are designed to be low intensity.
  • Geriatricians and pharmacists will each need to take part in a one-hour workshop during the three-month implementation phase.
  • During the intervention phase, geriatricians and pharmacists will meet once a week to discuss any proactive deprescribing opportunities. They can choose how this happens – either at a set time or ad hoc and the meeting can be a brief as a few minutes.